India to Nigeria: Domperidone Export Trade Route

The India to Nigeria Domperidone corridor is one of India's established pharmaceutical export routes, with 55 shipments documented worth a combined $2.8M USD. The route is dominated by VANTAGE INTERNATIONAL (INDIA) INC, which alone accounts for roughly 81% of all export value, reflecting the consolidated nature of India's domperidone manufacturing sector.

Across 15 active suppliers, the average shipment value stands at $50.0K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 76% of all shipments, consistent with domperidone's non-urgent bulk-order profile.

Shipment activity peaks during January–March, with an average transit time of 34 days port-to-port. The route has recorded an annual growth rate of 18.4%, placing it at rank #13 among India's top domperidone export destinations globally.

On the import side, key buyers of Indian domperidone in Nigeria include NA, MICRO NOVA PHARMACEUTICALS IND, LEOTETRA HEALTHCARE LTD., and 13 others. NA is the single largest importer with 6 shipments valued at $2.2M USD.

India's domperidone exports to Nigeria are driven primarily by a handful of large-scale manufacturers. VANTAGE INTERNATIONAL (INDIA) INC with 5 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 15 active exporters signals a competitive but concentrated market — buyers in Nigeria benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — VANTAGE INTERNATIONAL (INDIA) INC, INNOVA CAPTAB LIMITED, MICRO LABS LIMITED — together account for 92% of total trade value on this route. The average shipment value of $50.0K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

Beyond the primary product category, shipments on this route include closely related formulations such as hyperex-sr capsules [rabeprazole sodium& domperidone (sr) capsules] batch no: i417e3003 mfg & exp date: dec-23 & nov-26nos and hyperex-sr capsules [rabeprazole sodium& domperidone (sr) capsules] batch no:i417e3002 mfg & exp date:dec-23 & nov-26nos, suggesting that buyers in Nigeria tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, NA is the largest importer with 6 shipments worth $2.2M USD — representing 82% of all domperidone imports from India on this route. A total of 16 buyers are active on this corridor.